Pathological and clinical heterogeneity of presenilin 1 gene mutations

Journal of Alzheimer's Disease

Volumn 6, Issue 5, 2004, Pages 475-482

  Menéndez, Manuel ^a,b  

^a Central University Hospital of Asturias   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Alzheimer's disease; Heterogeneity; Mutation; Pathology; Phenotype; Presenilin

Indexed keywords

PRESENILIN 1; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; CLINICAL FEATURE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HEREDITY; HISTOPATHOLOGY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; AGED; GENE LIBRARY; GENETICS; METABOLISM; PATHOLOGY; POINT MUTATION;

AGED; ALZHEIMER DISEASE; GENE LIBRARY; HUMANS; MEMBRANE PROTEINS; PHENOTYPE; POINT MUTATION; PRESENILIN-1;

EID: 16644396131     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6503     Document Type: Review

References (70)

1. Alzheimer's Disease Collaborative Group The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families, Nat Genet 11(2) (1995), 219-223.
2. Z. Amtul, P.A. Lewis, S. Piper, R. Crook, M. Baker, K. Findlay et al., A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch, Neurobiol Dis 9(2) (2002), 269-273.
3. A. Assini, MD; L. Terreni, PhD; R. Borghi, PhD; L. Giliberto, MD; Piccini et al., Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation, Neurology 60(1) (2003), 150-551.
4. K. Bales, J.C. Dodart, R.B. DeMattos, D. Holtzman and S.M. Paul, Apolipoprotein E, Amyloid, and Alzheimer Disease, Molecular Interventions 2 (2002), 363-375.
5. C. Ballerini, B. Nacmias, G. Rombola et al., HLA-A2 allele is associated with age at onset of Alzheimer's disease, Ann Neurol 45 (1999), 397-400.
6. W.S. Brooks, J.B. Kwok, J.J. Kril, G.A. Broe, P.C. Blumbergs and A.E. Tannenberg, Alzheimer's disease with spastic paraparesis and cotton wool plaques: two pedigrees with PS-1 exon 9 deletions, Brain Apr 126(Pt 4) (2003), 783-791.
7. D. Campion, A. Brice, C. Dumanchin, M. Puel, M. Baulac, V. De La Sayette et al., A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years, Neuroreport 7(10) (1996), 1582-1584.
8. R. Crook, A. Verkkoniemi, J. Perez-Tur, N. Mehta, M. Baker, H. Houlden, M. Farrer et al., A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1, Nat Med 4(4) (1998), 452-455.
9. M. Cruts, C.M. van Duijn, H. Backhovens, M. Van den Broeck, A. Wehnert, S. Serneels et al., Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease, Hum Mol Genet 7(1) (1998), 43-51.
10. B. Dermaut, S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, U. Lubke et al., Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation, Brain 124(Pt 12) (2001), 2383-2392.
11. B. Dermaut, M. Cruts, H. Backhovens, U. Lubke, B. Van Everbroeck et al., Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion, J Neurol 247(5) (2000), 364-368.
12. A. Doan, G. Thinakaran, D.R. Borchelt, H.H. Slunt, T. Ratovitsky, M. Podlisny, D.J. Selkoe et al., Protein topology of presenilin 1, Neuron 17 (1996), 1023-1030.
13. M. Ezquerra, C. Carnero, R. Blesa, J.L. Gelpi, F. Ballesta and R. Oliva, A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures, Neurology 52(3) (1999), 566-570.
14. U. Finckh, Müller-Thomsen, U. Mann, C. Eggers, J. Marksteiner, W. Meins et al., High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analices of tour different genes, Am. J. Hum. Genet 66 (2000), 110-117.
15. N.C. Fox, A.M. Kennedy, R.J. Harvey, P.L. Lantos, P.K. Roques et al, Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor, Brain 120(Pt 3) (1997), 491-501.
16. H. Furuya, M. Yasuda, K.J. Terasawa, K. Tanaka, H. Murai et al., A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer's disease with myoclonus and generalized convulsion, J Neurol Sci 209(1-2) (2003), 75-77.
17. R. Gantier, C. Dumanchin, D. Campion, C. Loutelier, C. Lange, J. Gagnon et al., The L392V mutation of presenilin 1 associated with autosomal dominant early-onset Alzheimer's disease alters the secondary structure of the hydrophilic loop, Neuroreport 10(14) (1999), 3071-3074.
18. P. Giannakopoulus, E. Kövari, L. Bueée, J. Shioi et al., Presenilin-1 expression in Pick's disease, Acta Neuropathol 98 (1999), 488-492.
19. P. Giannakopoulus, E. Kövari, A. Savioz, F. De Bilbao et al., Differential distribution of presenilin-1, Bax, and Bcl-Xl in Alzheimer's disease and frontotemporal dementia, Acta Neuropathol 98 (1999), 141-149.
20. J.S. Goldman, B. Reed, R. Gearhart, J.H. Kramer, B.L. Miller, Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation, Int J Geriatr Psychiatry 17(7) (2002), 49-51.
21. T. Gomez-Isla, W.B. Growdon, M.J. McNamara, D. Nochlin, T.D. Bird et al., The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors, Brain 122(9) (1999), 1709-1719.
22. Q. Guo, K. Furukawa, B.L. Sopher et al., Alzheimer's PS1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide, Neuroreport 8 (1996), 379-383.
23. J. Hardy, Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease, Am J Med Genet 60 (1995), 456-460.
24. R.J. Harvey, D. Ellison, J. Hardy, M. Hutton, P.K. Roques, J. Collinge et al., Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine->serine (L250S) substitution at codon 250 of the presenilin 1 gene, J Neurol Neurosurg Psychiatry 64(1) (1998), 44-49.
25. J.M. Heckmann, W.C. Low, C. Villiers Cd, S. Rutherfoord, A. Vorster, H. Rao, C.M. Morris, R.S. Ramesar and R.N. Kalaria, Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease, Brain 65 (2003), 1123-1126.
26. S.S. Hebert, V. Bourdages, C. Godin, M. Ferland, M. Carreau and G. Levesque, Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1), Neurobiol Dis 13(3) (2003), 238-245.
27. H. Houlden, M. Baker, E. McGowan, P. Lewis and M. Hutton, Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations, Ann Neurol 48(5) (2000), 806-808.
28. H. Houlden, R. Crook, R.J. Dolan, J. McLaughlin, T. Revesz and J. Hardy, A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies, Neurosci Lett 313(1-2) (2001), 93-95.
29. M. Hull, B.L. Fiebich, P. Dykierek, K. Schmidtke, E. Nitzsche et al., Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139, Eur Arch Psychiatry Clin Neurosci 248(3) (1998), 123-129.
30. M.L. Jacquemont, D. Campion, V. Hahn, C. Tallaksen, T. Frebourg, A. Brice et al., Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease, J Med Genet 39(2) (2002), E2.
31. J. Jankowsky, D. Fadale, J. Anderson, G. Xu, V. Gonzales et al., Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum Mol Genet 13(2) (2004), 159-170.
32. J.C. Janssen, P.L. Lantos, N.C. Fox, R.J. Harvey, J. Beck et al., Autopsy-confirmed familial early-onset Alzheimer disease caused by the 1153V presenilin 1 mutation, Arch Neurol 58(6) (2004), 953-958.
33. J.C. Janssen, M. Hall, N.C. Fox, R.J. Harvey, J. Beck, A. Dickinson et al., Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study, Brain 123 (Pt 5) (2000), 894-907.
34. J.K. Johnson, E. Head, R. Kim, A. Starr and C.W. Cotman, Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease, Arch Neurol 56(10) (1999), 1233-1239.
35. A. Kowalska, C. Forsell, J. Florczak, D. Pruchnik-Wolinska, R. Modestowicz et al., A Polish pedigree with Alzheimer's disease determined by a novel mutation in exon 12 of the presenilin 1 gene: clinical and molecular characterization, Folia Neuropathol 37(1) (1999), 57-61.
36. J.B. Kwok, K. Taddei, M. Hallupp, C. Fisher, W.S. Brooks, G.A. Broe et al., Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype, Neuroreport 8(6) (1997), 1537-1542.
37. J.B. Kwok, G.M. Halliday, W.S. Brooks, G. Dolios, H. Laudon, O. Murayama, M. Hallupp et al., Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy, J Biol Chem 278(9) (2003), 6748-6754.
38. A.J. Larner and D.G. du Plessis, Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study, Eur J Neurol 10(3) (2003), 319-323.
39. C.F. Lippa, H. Fujiwara, D.M. Mann, B. Giasson, M. Baba et al., Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes, Am J Pathol 153(5) (1998), 1365-1370.
40. F. Lopera, A. Ardilla, A. Martinez, L. Madrigal, J.C. Arango-Viana, C.A. Lemere et al., Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation, JAMA 277(10) (1997), 793-799.
41. D.M. Mann, S.M. Pickering-Brown, A. Takeuchi, T. Iwatsubo, Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease, Am J Pathol 58(6) (2001), 2165-2175.
42. W. Marui, E. Iseki, N. Sugiyama, T. Matsumura, K. Suzuki et al., A Japanese family with familial Alzheimer's disease associated with presenilin 1 mutation: relationship between younger age of onset and ApoE gene polymorphism, No To Shinkei 55 (2003), 349-353.
43. M. Matsubara-Tsutsui, M. Yasuda, H. Yamagata, T. Nomura, K. Taguchi, K. Kohara, K. Miyoshi and T. Miki, Molecular evidence of presenilin 1 mutation in familial early onset dementia, Am J Med Genet 114(3) (1997), 292-298.
44. S. Mejia, M. Giraldo, D. Pineda, A. Ardila and F. Lopera, Nongenetic factors as modifiers of the age of onset of familial Alzheimer's disease, Int Psychogeriatr 15(4) (2003), 337-349.
45. M. Melanson, J. Nalbantoglu, S. Berkovic, C. Melmed, E. Andermann et al., Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease, Neurology 49(6) (2002), 1732-1733.
46. J. Miklossy, K. Taddei, D. Suva, G. Verdile, J. Fonte, C. Fisher et al., Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease, Neurobiol Aging 24(5) (2003), 655-662.
47. S. O'Riordan, P. McMonagle, J.C. Janssen, N.C. Fox, M. Farrell, J. Collinge et al., Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities, Neurology 59(7) (2002), 1108-1110.
48. D.T. Peng, X.H. Xu, Y. Feng and L. Peng, Study on the mechanism of Alzheimer disease-related gene presenilin-1, Zhonghua Nei Ke Za Zhi 42(8) (2003), 537-540.
49. F. Portet, Y. Dauvilliers, D. Campion, G. Raux, J.J. Hauw, O. Lyon-Caen, W. Camu and J. Touchon, Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu), Neurology 61(8) (2003), 1136-1137.
50. R. Queralt, M. Ezquerra, A. Lleo, M. Castellvi, J. Gelpi, I. Ferrer, N. Acarin, L. Pasarin, R. Blesa and R. Oliva, A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances, J Neurol Neurosurg Psychiatry 72(2) (2000), 266-269.
51. G. Raux, R. Gantier, C. Martin, Y. Pothin, A. Brice, T. Frebourg and D. Campion, A novel presenilin 1 missense mutation (L153V) segregating with early-onset autosomal dominant Alzheimer's disease, Hum Mutat 16(1) (2003), 95.
52. G. Raux, R. Gantier, C. Thomas-Anterion, J. Boulliat, P. Verpillat, D. Hannequin, A. Brice, T. Frebourg and D. Campion, Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation, Neurology 55(10) (2003), 1577-1578.
53. A.A. Rensink, R.M. de Waal, B. Kremer and M.M. Verbeek, Pathogenesis of cerebral amyloid angiopathy, Brain Res Rev 43(2) (2003), 207-223.
54. G.A. Rippon, R. Crook, M. Baker, E. Halvorsen, S. Chin and M. Hutton, Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia, Arch Neurol 60(6) (2003), 884-888.
55. I. Romero, P. Jorgensen, G. Bolwig, P.E. Fraser, E. Rogaeva, D. Mann et al., A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease, Neuroreport 10(11) (2000), 2255-2260.
56. C.E. Shepherd, G.C. Gregory, J.C. Vickers, W.S. Brooks, J.B. Kwok, P.R. Schofield et al., Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques, Neurobiol Dis 15(1) (2001), 115-119.
57. A.B. Singleton, R. Hall, C.G. Ballard, R.H. Perry, J.H. Xuereb et al., Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation, Brain 123(Pt 12) (2001), 2467-2674.
58. M.J. Smith, J.B. Kwok, C.A. McLean, J.J. Kril, G.A. Broe, G.A. Nicholson et al., Variable phenotype of Alzheimer's disease with spastic paraparesis, Ann Neurol 49(1) (2001), 125-129.
59. N. Sodeyama, T. Iwata, K. Ishikawa, H. Mizusawa, M. Yamada, Y. Itoh et al., Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile), J Neurol Neurosurg Psychiatry 71(4) (1995), 556-557.
60. H. Steiner, T. Revesz, M. Neumann, H. Romig, M.G. Grim, B. Pesold et al., A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques, J Biol Chem 276(10) (2002), 7233-7239.
61. S. Sorbi, B. Nacmias, P. Forleo, S. Piacentini, R. Sherrington et al., Missense mutation of S182 gene in Italian families with early-onset Alzheimer's disease, Lancet 346(8972) (2001), 439-440.
62. M. Takao, B. Ghetti, I. Hayakawa, E. Ikeda, Y. Fukuuchi et al., A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum, Acta Neuropathol (Berl) 104(2) (2002), 155-170.
63. M. Takao, B. Ghetti, J.R. Murrell, F.W. Unverzagt, G. Giaccone, F. Tagliavini et al., Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures, J Neuropathol Exp Neurol 60(12) (2001), 1137-1152.
64. K. Takeda, W. Araki and T. Tabira, Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2, Eur J Neurosci 19(2) (2004), 258-264.
65. D. Tang-Wai, P. Lewis, B. Boeve, M. Hutton, T. Golde et al., Familial frontotemporal dementia associated with a novel presenilin-1 mutation, Dement Geriatr Cogn Disord 14(1) (2002), 13-21.
66. A. Tedde, P. Forleo, B. Nacmias, C. Piccini, L. Bracco, S. Piacentini and S. Sorbi, A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset, Neurology 55(10) (2000), 1590-1591.
67. G. Thinakaran, The role of presenilins in Alzheimer's disease, J Clin Invest 104(10) (1999), 1321-1327.
68. T. Wisniewski, W.K. Dowjat, J.D. Buxbaum, O. Khorkova and S. Efthimiopoulos, A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years, Neuroreport 9(2) (1998), 217-221.
69. M. Masuda, K. Maeda, Y. Ikejiri, T. Kawamata, S. Kuroda and C. Tanaka, A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy, Neurosci Lett 232(1) (1997), 29-32.
70. O. Yokota, S. Terada, H. Ishizu, H. Ujike, T. Ishihara et al., Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases, Acta Neuropathol (Berl) 106(4) (2003), 348-356.